CAREDX INC (CDNA) Stock News

NASDAQ:CDNA - US14167L1035 - Common Stock

13.66 USD

+0.55 (+4.2%)

Last: 8/29/2025, 8:10:58 PM

13.8608 USD

+0.2 (+1.47%)

After Hours: 8/29/2025, 8:10:58 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

CDNA Latest News, Press Relases and Analysis

All

Press Releases

6 days ago - By: Benzinga

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

6 days ago - By: Yahoo Finance

CareDx Battles Reimbursement Uncertainty As Market Overlooks Long-Term Potential

6 days ago - By: Benzinga - Mentions: ACTU GYRE

This Actuate Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Tuesday

10 days ago - By: Zacks Investment Research

Do Options Traders Know Something About CareDx Stock We Don't?

11 days ago - By: CareDx, Inc.

CareDx to Participate in Wells Fargo Healthcare Conference

26 days ago - By: The Motley Fool

CareDx (CDNA) EPS Beats Sales Gain 14%

a month ago - By: Zacks Investment Research

Here's What Key Metrics Tell Us About CareDx (CDNA) Q2 Earnings

a month ago - By: Zacks Investment Research - Mentions: ESTA

CareDx (CDNA) Lags Q2 Earnings and Revenue Estimates

a month ago - By: CareDx, Inc.

CareDx Announces Appointment of Nathan Smith as Chief Financial Officer

a month ago - By: CareDx, Inc.

CareDx Announces Second Quarter 2025 Financial Results

a month ago - By: CareDx, Inc.

CareDx Announces Landmark KOAR Study Published in the American Journal of Transplantation

a month ago - By: CareDx, Inc.

CareDx Announces Landmark Data in AI-Powered Transplant Diagnostics Showcased in Over 40 Abstracts and 16 Oral Presentations at the 2025 World Transplant Congress

a month ago - By: CareDx, Inc.

CareDx to Report Second Quarter 2025 Financial Results

2 months ago - By: CareDx, Inc.

CareDx Announces Proposed Draft LCD That Affirms Surveillance Testing Coverage for Solid Organ Transplant Rejection

3 months ago - By: CareDx, Inc.

CareDx Announces Repurchase of 5% of Outstanding Shares

3 months ago - By: Johnson Fistel, PLLP

Johnson Fistel has Commenced an Investigation on Behalf of CareDx, Inc. Shareholders

4 months ago - By: CareDx, Inc.

CareDx to Participate in Upcoming Investor Conferences

4 months ago - By: Zacks Investment Research - Mentions: SHC

CareDx (CDNA) Tops Q1 Earnings Estimates

4 months ago - By: CareDx, Inc.

CareDx Reports First Quarter 2025 Results

4 months ago - By: CareDx, Inc.

CareDx Announces New Data on AlloSure Lung Presented at 2025 International Society for Heart and Lung Transplantation Meeting

4 months ago - By: CareDx, Inc.

CareDx Announces Presentation of 60 Abstracts Including 19 Oral Presentations at the 2025 International Society for Heart and Lung Transplantation Meeting

4 months ago - By: CareDx, Inc.

CareDx Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

5 months ago - By: CareDx, Inc.

CareDx to Report First Quarter 2025 Financial Results

5 months ago - By: Kahn Swick & Foti, LLC

CAREDX INVESTIGATION CONTINUED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Continues to Investigate the Officers and Directors of CareDx, Inc. - CDNA